E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/25/2006 in the Prospect News Biotech Daily.

Valentis receives warning on Nasdaq listing

New York, Aug. 25 - Valentis, Inc. said it received a letter from Nasdaq warning that it failed to comply with the minimum bid standard for continued listing.

The Burlingame, Calif., biotechnology company has 180 days to regain compliance, which it can do by having its stock close at $1.00 per share or more for at least 10 consecutive business days.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.